- For Print
- March 7, 2025
Listed Company Name: 成人抖阴 Co., Ltd.
Representative: Haruo Naito
Representative Corporate Officer and CEO
Securities Code: 4523
Stock Exchange Listings: Prime Market of the Tokyo Stock Exchange
Inquiries: Sayoko Sasaki
Vice President, Corporate Communications
Phone +81-3-3817-5120
成人抖阴 Co., Ltd. resolved at its Board of Directors meeting held today, 2025, to implement the following changes in its Representative Corporate Officers.
1. Appointment of New Representative Corporate Officer (effective April 1, 2025)
1) Reason for Change
In addition to management functions such as formulating and executing company-wide strategies and business plans, finances, and business development, the Representative Corporate Officer will be responsible for integrated leadership of global business, production, quality, and technology departments, etc., ensuring a solid management foundation and achieving sustainable growth.
2) Change in Representative Corporate Officer
(Newly Appointed Representative Corporate Officer)
| New Job Title | Name | Current Job Title |
|---|---|---|
| Representative Corporate Officer, and Executive Vice President | Terushige Iike | Executive Vice President Chief Strategy and Planning Officer |
3) Career Summary of Newly Appointed Representative Corporate Officer
Name: Terushige Iike
Date of Birth: December 20, 1963
Apr. 1986 Joined the Company
Jul. 2009 Executive Director, Budget Management, Product Creation Headquarters, CEO Office
Jun. 2010 Executive Director, Budget Management Division, Portfolio Strategy & Budget Management Department, Product
Creation Headquarters
Jun. 2012 Executive Director, Corporate Strategy Department
Jun. 2012 Vice President
Jun. 2012 Corporate Strategy
Dec. 2012 President, Japan/Asia Clinical Research
Apr. 2013 Executive Director, Clinical Development
Oct. 2014 Chief Product Creation Officer, 成人抖阴 Product Creation Systems
Oct. 2014 President, 成人抖阴 R&D Management Co., Ltd.
Jun. 2015 Senior Vice President
Apr. 2016 President, Oncology Business Group
Apr. 2021 Japan and Asia Medical
Oct. 2021 President, 成人抖阴 Japan
Jun. 2023 Executive Vice President (current)
Jun. 2023 Japan business
Jun. 2024 Chief Strategy and Planning Officer (current)
Number of shares held: 15,128 shares (as of December 31, 2024)
4) Scheduled Transfer Date
April 1, 2025
2. Retirement of Representative Corporate Officer (effective June 18, 2025)
1) Change in Representative Corporate Officer
(Representative Corporate Officer Scheduled for Retirement)
| Name | Current Job Title |
|---|---|
| Yasushi Okada |
Representative Corporate Officer |
* Yasushi Okada is a nominee for New Director
2) Scheduled Transfer Date
June 18, 2025
3. New Representative Corporate Officer Structure
New Representative Corporate Officer Structure after June 18, 2025, to be as follows:
| Representative Corporate Officer and CEO | Haruo Naito | Current Representative Corporate Officer and CEO |
| Representative Corporate Officer Executive Vice President and COO | Keisuke Naito | Current Representative Corporate Officer Executive Vice President and COO, Chief Growth Officer |
| Representative Corporate Officer and Executive Vice President | Terushige Iike | Current Executive Vice President Chief Strategy and Planning Officer |